Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1996-7-30
pubmed:abstractText
Since the development of cardiac prostheses, numerous chemical treatments have been assayed to prevent the process of their mineralization. The effect of chemical treatment with amino acids is assessed in a subcutaneous implantation model in rats. Pericardial tissue from young calves was treated with L-lysine, L-glutamine, L-arginine or L-glutamic acid, each at a concentration of 0.5 M, following treatment with 0.625% glutaraldehyde. Then, the tissue was implanted into young rats for periods of 21 and 60 d, after which the calcium accumulated was quantified by atomic absorption spectroscopy. Values similar to or higher than those found in control samples indicated a lack of effectiveness of these treatments. Only in the 21-d implantation samples treated with L-lysine and L-arginine was less calcium accumulated than in the control tissue. After 60 d of implantation, all groups showed high levels of calcium deposition. The values obtained after 60 d of subcutaneous implantation were 87.5 +/- 52.4 mg Ca2+ per g dry weight of tissue for L-lysine, 108.7 +/- 43.5 mg Ca2+ per g dry weight of tissue for L-glutamine, 130.4 +/- 22.4 mg Ca2+ per g dry weight of tissue for L-glutamic acid, 119.3 +/- 27.6 mg Ca2+ per g dry weight of tissue for L-arginine and 100.0 +/- 38.3 mg Ca2+ per g dry weight of tissue for the control group. Treatment with amino acids does not appear to prevent the calcification of cardiac bioprostheses or of collagen-based biomaterials when assayed in a model of subcutaneous implantation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0142-9612
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
571-5
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:8652775-Amino Acids, pubmed-meshheading:8652775-Analysis of Variance, pubmed-meshheading:8652775-Animals, pubmed-meshheading:8652775-Arginine, pubmed-meshheading:8652775-Bioprosthesis, pubmed-meshheading:8652775-Calcinosis, pubmed-meshheading:8652775-Calcium, pubmed-meshheading:8652775-Cardiomyopathies, pubmed-meshheading:8652775-Cattle, pubmed-meshheading:8652775-Female, pubmed-meshheading:8652775-Glutamic Acid, pubmed-meshheading:8652775-Glutamine, pubmed-meshheading:8652775-Glutaral, pubmed-meshheading:8652775-Heart Valve Prosthesis, pubmed-meshheading:8652775-Lysine, pubmed-meshheading:8652775-Pericardium, pubmed-meshheading:8652775-Rats, pubmed-meshheading:8652775-Rats, Wistar, pubmed-meshheading:8652775-Spectrophotometry, Atomic, pubmed-meshheading:8652775-Structure-Activity Relationship
pubmed:year
1996
pubmed:articleTitle
Calcification of pericardial tissue pretreated with different amino acids.
pubmed:affiliation
Servicio de Cirugia Experimental, Clinica Puerta de Hierro, Madrid, Spain.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't